HANSOH PHARMA(03692),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

03692 HANSOH PHARMA

Market Closed 10-30 16:08:08

32.360

-0.720

-2.18%

High33.260	Low32.140	Vol7.81M
Open33.080	D1 Closing33.080	Amplitude3.39%
Mkt Cap196.23B	Tradable Cap196.23B	Total Shares6.06B
T/O254.66M	T/O Rate0.13%	Tradable Shares6.06B
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"03692","market":"HK","secType":"STK","nameCN":"HANSOH PHARMA","latestPrice":32.36,"timestamp":1793347688007,"preClose":33.08,"halted":0,"volume":7813600,"delay":0,"changeRate":-0.021765417170495734,"floatShares":6064000000,"shares":6064000000,"eps":1.0970272878483556,"marketStatus":"Market Closed","change":-0.72,"latestTime":"10-30 16:08:08","open":33.08,"high":33.26,"low":32.14,"amount":254656326,"amplitude":0.033857,"askPrice":32.38,"askSize":30000,"bidPrice":32.36,"bidSize":38000,"shortable":3,"etf":0,"ttmEps":1.3066220185868063,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1793583000000},"marketStatusCode":7,"adr":0,"listingDate":1560441600000,"exchange":"SEHK","adjPreClose":33.08,"dividendRate":0.015421,"openAndCloseTimeList":[[1793323800000,1793332800000],[1793336400000,1793347200000]],"volumeRatio":0.588336971012663,"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/03692","defaultTab":"news","newsList":[{"id":"1180397060","title":"Movement Alert｜HANSOH PHARMA Intraday Rise 3.3% in Regular Trading, Innovation Drug Names Advance as ADC Out-licensing Theme Stays in Focus","url":"https://stock-news.laohu8.com/highlight/detail?id=1180397060","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1180397060?lang=en_us&edition=fundamental","pubTime":"2026-10-29 13:18","pubTimestamp":1793251131,"startTime":"0","endTime":"0","summary":"On October 29, HANSOH PHARMA posted an Intraday Rise of 3.3% in Regular Trading, with the shares trading at HK$33.24 and turnover at HK$197 million.The move is broadly consistent with continued...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Hansoh Pharma Rises on $400M Roche ADC Deal Momentum","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03692"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678459013","title":"Hansoh Pharmaceutical Group Stock Climbs 0.9% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2678459013","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678459013?lang=en_us&edition=fundamental","pubTime":"2026-10-28 16:33","pubTimestamp":1793176380,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Hansoh Pharmaceutical Group Co. Ltd. inched 0.9% higher to 32.14 Hong Kong dollars on what proved to be an all-around positive trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.2% to 23094.83.The stock's rise snapped a two-day losing streak.Hansoh Pharmaceutical Group Co. Ltd. closed 27% short of its 52-week high of HK$44.22, which the company reached Jan. 15.Trading volume totaled 12.3 million shares, compared to the 50-day average of 11.0 million shares.Data source: Dow Jones Market Data, FactSet","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03692","BK1589","BK1583","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678634453","title":"GSK Q3 Profit Tops Estimates on Oncology Sales; Declares Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2678634453","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678634453?lang=en_us&edition=fundamental","pubTime":"2026-10-28 15:12","pubTimestamp":1793171551,"startTime":"0","endTime":"0","summary":"GSK Q3 profit tops estimates on oncology sales; declares dividendOverviewUK pharma firm's Q3 sales rose 5% CER, slightly beating analyst expectationsQ3 adjusted EPS beat analyst expectations, driven b","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261028:nL2N46E08B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1309081286.SGD","LU0557290698.USD","LU0289739699.SGD","LU0321505868.SGD","LU1015430645.USD","IE0034235071.USD","IE00B3T34201.USD","IE00BWDBJ516.SGD","LU0109981661.USD","LU0225283273.USD","LU0575583348.USD","LU1064927863.SGD","LU1228905540.USD","LU1670756490.USD","LU0306807586.USD","SG9999001176.USD","LU2646069778.SGD","SG9999001176.SGD","LU0203347892.USD","LU2089984988.USD","LU1202635105.USD","LU0203345920.USD","BK5011","LU0306806265.USD","BK1589","LU0971552673.USD","LU1487256676.USD","IE00BQJZX424.USD","LU0211331839.USD","LU1098665638.USD","BK1583","03692","SGXZ57979304.SGD","LU0058720904.USD","LU0545562505.USD","LU0987226296.USD","LU1035777561.USD","BK1191","LU1400636491.USD","LU1228905037.USD","GSK.UK","LU0225771236.USD","LU1302929846.USD","LU0321505439.SGD","LU0985481810.HKD","LU1400636574.HKD","LU1645745479.HKD","LU2468319806.SGD","LU0161305163.EUR","LU0971552830.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148146956","title":"Movement Alert｜HANSOH PHARMA rises 3.02% in Regular Trading, innovation drug strength and ADC outbound theme stay in focus","url":"https://stock-news.laohu8.com/highlight/detail?id=1148146956","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148146956?lang=en_us&edition=fundamental","pubTime":"2026-10-28 11:25","pubTimestamp":1793157917,"startTime":"0","endTime":"0","summary":"On October 28, HANSOH PHARMA rose 3.02% intraday, trading at HK$32.8, with turnover of HK$214 million.The move aligned with a broader rally in innovation drug names, as market attention remained on...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"HANSOH PHARMA rises on Roche ADC deal with $400M upfront","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03692"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678174808","title":"Wave Life Sciences Q3 Revenue Jumps, Beats Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2678174808","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678174808?lang=en_us&edition=fundamental","pubTime":"2026-10-27 19:42","pubTimestamp":1793101337,"startTime":"0","endTime":"0","summary":"Wave Life Sciences Q3 revenue jumps, beats estimatesOverviewBiotechnology firm's Q3 revenue rose and beat analyst expectationsCompany reported smaller-than-expected pretax and net loss figuresCompany ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261027:nL2N46D0GE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1191","BK4007","WVE","03692","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678213141","title":"Hansoh Pharmaceutical Group Stock Slides 3.2% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2678213141","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678213141?lang=en_us&edition=fundamental","pubTime":"2026-10-27 16:30","pubTimestamp":1793089800,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Hansoh Pharmaceutical Group Co. Ltd. shed 3.2% to 31.84 Hong Kong dollars on what proved to be an all-around rough trading session for the Hong Kong stock market, with the Hang Seng Index falling 0.7% to 23041.32.This was the stock's second consecutive day of losses.Hansoh Pharmaceutical Group Co. Ltd. closed 28% below its 52-week high of HK$44.22, which the company achieved Jan. 15.Trading volume totaled 11.4 million shares, compared to the 50-day average of 11.0 million shares.Data source: Dow Jones Market Data, FactSet","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK1589","BK1583","03692"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678123121","title":"UK's Inspiration Healthcare H1 Underlying Revenue Rises on Neonatal Ventilation Segment","url":"https://stock-news.laohu8.com/highlight/detail?id=2678123121","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678123121?lang=en_us&edition=fundamental","pubTime":"2026-10-27 15:19","pubTimestamp":1793085573,"startTime":"0","endTime":"0","summary":"UK's Inspiration Healthcare H1 underlying revenue rises on neonatal ventilation segmentOverviewUK neonatal device maker's H1 revenue fell due to prior year one-off export ordersUnderlying H1 revenue r","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261027:nL2N46D06M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0689626769.HKD","BK1589","BK1583","LU0203345920.USD","BK1191","03692","LU0154245756.USD","IHC.UK","LU0154245673.USD","LU0511384066.AUD","LU0203347892.USD","BK4567","BK4588","LU0057025933.USD","MADE","CMI","IE000M9KFDE8.USD","BK4533","BK5020","LU0289961442.SGD","BK4585","LU0472753341.HKD","LU2463526074.USD","BK4149","LU0124676726.USD","LU0069063385.USD","LU0289739343.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678147081","title":"Pharming Group Q3 Revenue Rises on US Demand; Tightens Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2678147081","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678147081?lang=en_us&edition=fundamental","pubTime":"2026-10-27 14:11","pubTimestamp":1793081467,"startTime":"0","endTime":"0","summary":"Pharming Group Q3 revenue rises on US demand; tightens guidanceOverviewNetherlands biotech firm's preliminary Q3 revenue rose 21% yr/yrRUCONEST revenue up 14% and Joenja revenue up 58%, driven by dema","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261027:nL2N46D054:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK1589","03692","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678147693","title":"UK Stocks-Factors to Watch on October 27","url":"https://stock-news.laohu8.com/highlight/detail?id=2678147693","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678147693?lang=en_us&edition=fundamental","pubTime":"2026-10-27 13:59","pubTimestamp":1793080750,"startTime":"0","endTime":"0","summary":"UK Stocks-Factors to watch on October 27Oct 27 (Reuters)-Britain's FTSE 100.FTSEindex is seen opening down on Tuesday, with futuresFFIc1down 0.3%.* REVOLUT: The Bank of England hasordereda review of R","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261027:nL6N46D0AM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0550127509.SGD","LU0575583348.USD","BK1191","LU0306807586.USD","LU0557290698.USD","LU0738911758.USD","LU1989763427.SGD","BK1589","LU1920062954.HKD","IE00B3PB1722.GBP","LU0985481810.HKD","LU2023251221.USD","LU2028103732.USD","03692","LU0225284248.USD","LU1316543591.SGD","LU2242652126.USD","LU2242646821.SGD","LU0047473722.EUR","REVB.UK","LU0047473722.SGD","LU0321505868.SGD","LU0949170772.SGD","LU0997586606.USD","LU2271345857.HKD","IE00BGHQF631.EUR","LU2089284900.SGD","LU0306806265.USD","LU0211331839.USD","LU0158827781.USD","LU0048578792.EUR","LU0171293334.USD","LU2111349929.HKD","LU0321505439.SGD","LU0161305163.EUR","IE00B42XCP33.USD","LU1059921491.USD","BK5022","LU1015430645.USD","IE00BVYPNV92.GBP","RKT.UK","LU2401740654.USD","LU0225771236.USD","LU2242646235.USD","LU1119994140.HKD","LU1309081286.SGD","LU0997587240.USD","BK1583","LU1920063259.USD","IE00BDGV0183.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170605687","title":"UBS: Hansoh Pharma's Mo-Rez Shows Favorable Data in Platinum-Resistant Ovarian Cancer; Buy Rating Maintained with HK$50.8 Target Price","url":"https://stock-news.laohu8.com/highlight/detail?id=1170605687","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170605687?lang=en_us&edition=fundamental","pubTime":"2026-10-27 11:34","pubTimestamp":1793072053,"startTime":"0","endTime":"0","summary":"UBS has released a research report maintaining its \"Buy\" rating on Hansoh Pharma (03692) with a target price of HK$50.8.The investment bank noted that the updated data for Mo-Rez in the treatment of...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","EWH","BK1191","03692","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115599368","title":"Movement Alert｜HANSOH PHARMA Falls 3.1% in Regular Trading, Roche ADC deal momentum shows signs of cooling","url":"https://stock-news.laohu8.com/highlight/detail?id=1115599368","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115599368?lang=en_us&edition=fundamental","pubTime":"2026-10-27 11:25","pubTimestamp":1793071534,"startTime":"0","endTime":"0","summary":"On October 27, HANSOH PHARMA fell 3.1% in Regular Trading, trading at HK$31.88, with turnover of HK$165 million.The latest publicly discussed catalyst remains the company’s expanded ADC strategic...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Hansoh Pharma Falls as Roche ADC Deal Momentum Cools","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03692"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678511081","title":"Hansoh Pharma's Ris-Rez Cuts Progression or Death Risk by 67% in Phase 3 Osteosarcoma Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2678511081","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678511081?lang=en_us&edition=fundamental","pubTime":"2026-10-27 07:47","pubTimestamp":1793058468,"startTime":"0","endTime":"0","summary":"Hansoh Pharma's Ris-Rez cuts progression or death risk by 67% in Phase 3 osteosarcoma trialHansoh Pharma announced Oct. 27, 2026, that risvutatug rezetecan met the Phase 3 ARTEMIS-011 trial's primary ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261026:nNDL8SSk49:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1589","BK1191","03692","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678192124","title":"GSK, Hansoh's Bone Cancer Drug Delays Disease Progression in Late-Stage China Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2678192124","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678192124?lang=en_us&edition=fundamental","pubTime":"2026-10-26 23:30","pubTimestamp":1793028600,"startTime":"0","endTime":"0","summary":"GSK, Hansoh's bone cancer drug delays disease progression in late-stage China studyMADRID, Oct 26 (Reuters)-An experimental drug for a hard-to-treat bone cancer, being developed by Hansoh Pharmaceutic","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261026:nL3N46C119:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1046248800.SGD","LU1309081286.SGD","BK1191","LU0306807586.USD","GSK.UK","LU1481599808.USD","IE00BQJZX424.USD","LU2646069778.SGD","LU0557290698.USD","LU0306806265.USD","LU0225283273.USD","LU0058720904.USD","LU0987226296.USD","LU1481600234.SGD","IE00B3T34201.USD","LU1400636657.SGD","IE0034235071.USD","LU0971552673.USD","LU0225284248.USD","BK5011","LU0545562505.USD","LU2089984988.USD","LU0203345920.USD","LU1064927863.SGD","LU0211331839.USD","LU2468319806.SGD","LU1400636491.USD","LU1228905540.USD","LU1670756490.USD","SG9999001176.SGD","LU0203347892.USD","BK1583","03692","LU0289739699.SGD","LU0971552830.HKD","SG9999001176.USD","LU1202635105.USD","LU0321505439.SGD","LU0985481810.HKD","LU0109981661.USD","LU0161305163.EUR","BK1589","LU1228905037.USD","LU0225771236.USD","LU1035777561.USD","LU0575583348.USD","LU1015430645.USD","LU0321505868.SGD","LU1098665638.USD","LU1400636574.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678169671","title":"Hansoh Pharma's Dalmelitinib-Aumolertinib Improves Progression-Free Survival in Phase 3 Lung Cancer Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2678169671","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678169671?lang=en_us&edition=fundamental","pubTime":"2026-10-26 17:55","pubTimestamp":1793008508,"startTime":"0","endTime":"0","summary":"Hansoh Pharma's dalmelitinib-aumolertinib improves progression-free survival in Phase 3 lung cancer trialHansoh Pharma presented Phase 3 results for dalmelitinib combined with aumolertinib at the ESMO","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261026:nNDL2s3KxF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1589","BK1191","03692","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678700184","title":"How Roche ADC Deal At Hansoh Pharmaceutical Group (SEHK:3692) Has Changed Its Investment Story","url":"https://stock-news.laohu8.com/highlight/detail?id=2678700184","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678700184?lang=en_us&edition=fundamental","pubTime":"2026-10-25 13:35","pubTimestamp":1792906541,"startTime":"0","endTime":"0","summary":"Hansoh Pharmaceutical Group reported that its subsidiaries entered a collaboration and license agreement with Roche covering multiple Antibody Drug Conjugate programs, with Hansoh receiving an upfront US$400 million payment, a US$110 million first anniversary payment, potential milestone payments above US$15b, and retaining commercialization rights in the Chinese Mainland, Hong Kong, Macau and Taiwan.\nThe structure of the Roche agreement underscores Hansoh Pharmaceutical Group's push to...","market":"nz","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6121000-choice2-card/1788952923351","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6121000-choice2-card/1788952923351"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-3692/hansoh-pharmaceutical-group-shares/news/how-roche-adc-deal-at-hansoh-pharmaceutical-group-sehk3692-h","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-3692/hansoh-pharmaceutical-group-shares/news/how-roche-adc-deal-at-hansoh-pharmaceutical-group-sehk3692-h","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1191","BK1583","03692","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678869391","title":"Hansoh Pharma Reports 61.3% Response Rate for HS-20122 in Phase 1 Trial in EGFR-Mutant Lung Cancer After TKI Failure","url":"https://stock-news.laohu8.com/highlight/detail?id=2678869391","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678869391?lang=en_us&edition=fundamental","pubTime":"2026-10-25 08:06","pubTimestamp":1792886811,"startTime":"0","endTime":"0","summary":"Hansoh Pharma reports 61.3% response rate for HS-20122 in Phase 1 trial in EGFR-mutant lung cancer after TKI failureHansoh Pharma presented Phase 1 results for cancer drug HS-20122 at ESMO in Madrid o","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261025:nNDL74GdlS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1191","03692","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677397011","title":"Hansoh Pharmaceutical Group (SEHK:3692) Moved Today, What Is Behind The Attention?","url":"https://stock-news.laohu8.com/highlight/detail?id=2677397011","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677397011?lang=en_us&edition=fundamental","pubTime":"2026-10-24 04:28","pubTimestamp":1792787323,"startTime":"0","endTime":"0","summary":"Hansoh Pharmaceutical Group (SEHK:3692) just signed a wide-ranging collaboration and license agreement with Roche covering multiple Antibody Drug Conjugate programs, anchored by a US$400 million upfront payment and substantial milestone potential.\nHansoh Pharmaceutical Group has enjoyed a sharp bump in interest, with a 1-day share price return of 3.58% taking the stock to HK$33.0, following a softer 30-day share price decline of 5.55% and a year-to-date share price return down 9.44%.\nScan how...","market":"sg","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6121000-choice2-card/1788952923351","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6121000-choice2-card/1788952923351"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-3692/hansoh-pharmaceutical-group-shares/news/hansoh-pharmaceutical-group-sehk3692-moved-today-what-is-beh","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-3692/hansoh-pharmaceutical-group-shares/news/hansoh-pharmaceutical-group-sehk3692-moved-today-what-is-beh","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1583","DCF","03692","BK1589","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102396537","title":"Hansoh Pharma Shares Rise Nearly 4% as Goldman Sachs Says Roche Deal Boosts Visibility on Global Value Realization","url":"https://stock-news.laohu8.com/highlight/detail?id=1102396537","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102396537?lang=en_us&edition=fundamental","pubTime":"2026-10-23 12:00","pubTimestamp":1792728039,"startTime":"0","endTime":"0","summary":"Hansoh Pharma (HANSOH PHARMA) (03692) shares climbed nearly 4% in morning trading, rising 3.58% as of press time to HK$33, with turnover of HK$410 million.Goldman Sachs published a research report...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03692","BK1191","LU0868494708.USD","LU1868837136.USD","LU0048573561.USD","LU2237443465.HKD","LU2237443622.USD","LU2237443978.SGD","IE00B19Z3B42.SGD","LU2237443895.HKD","GSX","LU2265009873.SGD","BK4127","LU1668664300.SGD","LU2471134952.CNY","LU2237443549.SGD","LU0742534661.SGD","LU0251131958.USD","LU0942090050.USD","LU0106831901.USD","IE00BFXG1179.USD","IE00BSNM7G36.USD","IE0004086264.USD","BK4504","BK4552","LU0096364046.USD","BK4533","LU0210536198.USD","LU1804176565.USD","BK1589","IE0034235188.USD","LU2237443382.USD","IE00B19Z3581.USD","LU1791807156.HKD","LU1868836914.USD","LU0061475181.USD","LU2750360997.AUD","LU1868836591.USD","BK4585","LU0868494617.USD","BK4588","LU1868837300.USD","BK1583","LU1868836757.USD","BK4516","IE0002270589.USD","LU2471134523.USD","LU0345770308.USD","GS","LU2750360641.GBP","LU1144417596.USD","LU2237438978.USD","LU2471134796.USD","LU1894683348.USD","LU1894683264.USD","LU0251142724.SGD","BK4550","LU2896262040.SGD","IE0004091025.USD","LU0345770993.USD","LU2471134879.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1112789989","title":"Movement Alert｜HANSOH PHARMA Intraday Rise 3.01% in Regular Trading, broker reiteration highlights continued ADC platform value realization","url":"https://stock-news.laohu8.com/highlight/detail?id=1112789989","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1112789989?lang=en_us&edition=fundamental","pubTime":"2026-10-23 10:37","pubTimestamp":1792723058,"startTime":"0","endTime":"0","summary":"On October 23, HANSOH PHARMA recorded an Intraday Rise of 3.01% in Regular Trading, with the shares trading at HK$32.84 and turnover at HK$306 million.The clearest catalyst in publicly available...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"HANSOH PHARMA Jumps as Broker Reiterates Outperform on Roche ADC Deal","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03692"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123306703","title":"CICC Keeps Outperform Rating on Hansoh Pharma with HK$52 Target as ADC Platform Value Continues to Materialize","url":"https://stock-news.laohu8.com/highlight/detail?id=1123306703","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123306703?lang=en_us&edition=fundamental","pubTime":"2026-10-23 10:00","pubTimestamp":1792720820,"startTime":"0","endTime":"0","summary":"CICC has released a research report maintaining its Outperform rating on Hansoh Pharma (03692) with a target price of HK$52.00, corresponding to price-to-earnings ratios of 43.9 times and 42.3 times...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EWH","BK1191","BK1583","BK1589","03692"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.0194},{"period":"1month","weight":-0.0833},{"period":"3month","weight":0.0137},{"period":"6month","weight":-0.1151},{"period":"1year","weight":-0.0401},{"period":"ytd","weight":-0.0901}],"compareEarnings":[{"period":"1week","weight":0.0087},{"period":"1month","weight":-0.0536},{"period":"3month","weight":-0.1001},{"period":"6month","weight":-0.0963},{"period":"1year","weight":-0.1137},{"period":"ytd","weight":-0.0911}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"Hansoh Pharmaceutical Group Company Ltd is an investment holding company primarily engaged in the research and development, production and sale of a series of pharmaceutical products. The Company’s innovative drug products include Ameile, Hansoh Xinfu, Mailingda, Fulaimei, Hengmu, XINYUE, Saint Luolai and other products. The Company’s drug products are mainly used in oncology, anti-infective diseases, central nervous system (CNS) diseases, metabolic diseases and other therapeutic areas. The Company mainly conducts its business in the domestic market.","yearOnYearQuotes":[{"month":1,"riseRate":0.714286,"avgChangeRate":-0.002579},{"month":2,"riseRate":0.428571,"avgChangeRate":-0.012814},{"month":3,"riseRate":0.428571,"avgChangeRate":0.023358},{"month":4,"riseRate":0.571429,"avgChangeRate":0.033967},{"month":5,"riseRate":0.571429,"avgChangeRate":-0.005202},{"month":6,"riseRate":0.571429,"avgChangeRate":0.039399},{"month":7,"riseRate":0.625,"avgChangeRate":0.011392},{"month":8,"riseRate":0.75,"avgChangeRate":0.028858},{"month":9,"riseRate":0.625,"avgChangeRate":-0.028026},{"month":10,"riseRate":0.125,"avgChangeRate":-0.009001},{"month":11,"riseRate":0.714286,"avgChangeRate":0.063438},{"month":12,"riseRate":0.571429,"avgChangeRate":0.016882}],"exchange":"SEHK","name":"HANSOH PHARMA","nameEN":"HANSOH PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.52.1","shortVersion":"4.52.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"HANSOH PHARMA(03692),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest HANSOH PHARMA(03692) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"HANSOH PHARMA,03692,HANSOH PHARMA股票,HANSOH PHARMA股票老虎,HANSOH PHARMA股票老虎国际,HANSOH PHARMA行情,HANSOH PHARMA股票行情,HANSOH PHARMA股价,HANSOH PHARMA股市,HANSOH PHARMA股票价格,HANSOH PHARMA股票交易,HANSOH PHARMA股票购买,HANSOH PHARMA股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"HANSOH PHARMA(03692),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest HANSOH PHARMA(03692) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}